Abstract
The American Chemical Society Committee on Patents and Related Matters (CPRM) provides information and guidance to ACS and the broader chemistry community about patent and other intellectual property (IP) issues. During the pandemic, the world witnessed the power of science and innovation, including the creation of mRNA vaccines. The rapid deployment of these technologies was made possible by years of innovations incentivized by IP systems worldwide. This system has always played a vital role in incentivizing the discovery, development, and commercialization of novel scientific technologies that benefit not only those rewarded with IP rights but also the public. However, some have argued that our IP system is a hindrance and has contributed to the worldwide vaccine shortage, particularly in developing countries. At an October 2020 World Trade Organization (WTO) meeting, India and South Africa proposed waiving certain IP protections provided by the WTO Agreement on Trade-Related Aspects of Intellectual Property
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
